GGrantIndex
← Search

Rapid Point of Care Diagnostics to Determine Cytomegalovirus Infection Serostatus

$1,500,000N44FY2019AINIH

Zymeron Corporation, Durham NC

Investigators

Abstract

This proposal aims to develop a point-of-care test to measure the antibodies from human blood and to determine the serostatus of cytomegalovirus (CMV) infection.

View original record on NIH RePORTER →